Publication & Citation Trends
Publications
0 total
Anthracycline-containing and taxane-containing chemotherapy for early-stage operable breast cancer: a patient-level meta-analysis of 100 000 women from 86 randomised trials OA
Cited by 113
Semantic Scholar
Randomized Trial of Standard Adjuvant Chemotherapy Regimens Versus Capecitabine in Older Women With Early Breast Cancer: 10-Year Update of the CALGB 49907 Trial. OA
Cited by 61
Semantic Scholar
Evaluating the addition of bevacizumab to endocrine therapy as first-line treatment for hormone receptor-positive metastatic breast cancer: a pooled analysis from the LEA (GEICAM/2006-11_GBG51) and CALGB 40503 (Alliance) trials. OA
Cited by 18
Semantic Scholar
Increasing the dose intensity of chemotherapy by more frequent administration or sequential scheduling: a patient-level meta-analysis of 37 298 women with early breast cancer in 26 randomised trials OA
Cited by 308
Semantic Scholar
Use of the National Institutes of Health Consensus Guidelines Improves the Diagnostic Sensitivity of Gastrointestinal Graft-Versus-Host Disease. OA
Cited by 7
Semantic Scholar
Predictors of duloxetine response in patients with oxaliplatin‐induced painful chemotherapy‐induced peripheral neuropathy (CIPN): a secondary analysis of randomised controlled trial – CALGB/alliance 170601 OA
Cited by 58
Semantic Scholar
Evaluating the addition of bevacizumab (Bev) to endocrine therapy as first-line treatment for hormone-receptor positive (HR+)/HER2-negative advanced breast cancer (ABC): Pooled-analysis from the LEA (GEICAM/2006-11_GBG51) and CALGB 40503 (Alliance) trials.
Cited by 1
Semantic Scholar
Axillary Management of Stage II/III Breast Cancer in Patients Treated with Neoadjuvant Systemic Therapy: Results of CALGB 40601 (HER2-Positive) and CALGB 40603 (Triple-Negative). OA
Cited by 9
Semantic Scholar
Research Topics
Breast Cancer Treatment Studies
(60)
Cancer Treatment and Pharmacology
(50)
HER2/EGFR in Cancer Research
(32)
Advanced Breast Cancer Therapies
(16)
Breast Lesions and Carcinomas
(15)
Affiliations
Northwestern University
University of North Carolina at Chapel Hill
Roche (Switzerland)
University of Maryland, Baltimore
Novartis (Switzerland)